Source: Multiple Myeloma News — ScienceDaily
A new type of CAR T-cell therapy more than triples the expected length of remission for multiple myeloma patients who have relapsed several times, according to an international clinical trial.
Read More
by | Jun 15, 2021 | Myeloma News | 0 comments
Source: Multiple Myeloma News — ScienceDaily
A new type of CAR T-cell therapy more than triples the expected length of remission for multiple myeloma patients who have relapsed several times, according to an international clinical trial.
Read More